Kangstem Biotech Co., Ltd. (KOSDAQ:217730)

Kangstem Biotech Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Feb 26, 2026	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	205,979	133,971	109,830	124,057	196,458	169,714
Market Cap Growth	88.44%	21.98%	-11.47%	-36.85%	15.76%	-62.62%
Enterprise Value	187,768	129,761	85,183	115,828	180,137	145,899
Last Close Price	2190.00	2003.15	2103.33	2375.78	5033.61	5179.98
PS Ratio	16.12	10.55	6.74	10.00	21.50	28.26
PB Ratio	4.34	2.67	2.08	1.74	4.04	2.47
P/TBV Ratio	4.37	2.82	2.27	1.85	3.91	2.52
EV/Sales Ratio	14.70	10.21	5.23	9.34	19.71	24.30
Debt / Equity Ratio	0.16	0.27	0.25	0.20	0.37	0.45
Net Debt / Equity Ratio	-0.38	-0.47	-0.44	-0.60	-0.41	-0.25
Net Debt / EBITDA Ratio	1.13	1.26	1.40	2.26	1.26	0.82
Net Debt / FCF Ratio	1.13	1.33	1.19	1.97	1.16	0.60
Asset Turnover	0.20	0.16	0.18	0.13	0.09	0.06
Inventory Turnover	14.77	21.16	18.57	17.37	26.05	5.89
Quick Ratio	2.23	2.07	2.73	3.38	3.18	2.36
Current Ratio	2.97	2.55	3.22	3.80	3.67	2.69
Return on Equity (ROE)	-26.14%	-45.17%	-32.55%	-36.40%	-33.65%	-45.39%
Return on Assets (ROA)	-19.06%	-17.59%	-13.99%	-15.31%	-11.93%	-15.49%
Return on Capital Employed (ROCE)	-37.70%	-36.40%	-31.00%	-26.40%	-26.60%	-24.90%
Earnings Yield	-4.02%	-16.38%	-18.43%	-17.21%	-9.40%	-14.52%
FCF Yield	-7.80%	-13.35%	-17.82%	-17.43%	-8.67%	-16.89%
Buyback Yield / Dilution	-42.69%	-7.02%	-36.23%	-24.89%	-6.99%	-13.71%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.